Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,889,777 papers from all fields of science
Search
Sign In
Create Free Account
ponalrestat
Known as:
3-(4-Bromo-2-fluorobenzyl)-3,4-dihydro-4-oxo-1-phthalazineacetic Acid
, 3-(4-bromo-2-fluorobenzyl)-3,4-dihydro-4-oxo-3H-phthalazin-1-ylacetic acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (3)
Enzyme Inhibitors
Hypoglycemic Agents
Phthalazines
Narrower (2)
ICI 128436
Statil
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
25th Annual Meeting of the European Association for the Study of Diabetes Lisbon, Portugal, 20–23 September 1989
J. O'neil
,
G. Eisenbarth
Diabetologia
2004
Corpus ID: 9351284
1. Effect of diabetic autonomic neuropathy on pregnancy outcome K. E. J. Airaksinen, M. Anttila, M. Linnaluoto, P. Jouppila, J. T…
Expand
1994
1994
DER EINFLUSS DES ALDOSE-REDUKTASE-INHIBITORS PONALRESTAT AUF DIE DIABETISCHE POLYNEUROPATHIE : EINE EINJAHRIGE DOPPELBLINDSTUDIE
H. Stracke
,
E. Dietrich
1994
Corpus ID: 77828977
1989
1989
The Effect of Aldose Reductase Inhibition on Erythrocyte Polyols and Galactitol Accumulation in Diabetic Patients
C. Airey
,
D. Price
,
J. Wales
,
J. Kemp
,
C. Perkins
Diabetic Medicine
1989
Corpus ID: 34988403
Erythrocyte sorbitol level has previously been used as a measure of the efficacy of aldose reductase inhibitors, but its value is…
Expand